Advancing medicine,
improving lives.
-
Brisbane
Australia’s only Phase l unit dedicated to early clinical development of New Biological Entities (NBE’s), Biosimilars and Vaccines.
-
60-bed facility, co-located within the Royal Brisbane and Women’s Hospital
-
275 trials completed
-
-
Melbourne
A leading Phase I facility capable of delivering patients for pharmacokinetic studies in hepatic and renal patients.
-
Over 111 beds (95 inpatient, 16 outpatient), co-located within the Alfred Hospital
-
450 trials completed
-
-
Minneapolis
A leading Phase I facility capable of delivering patients for pharmacokinetic studies in hepatic and renal patients.
-
50-bed facility, co-located within the University Enterprise Labs (UEL) and Medical Alley
-
120 trials completed
-
-
London
A world-renowned early phase unit specialising in first-in-human trials and studies in healthy and patient volunteers.
-
145-bed facility, purpose-built for Phase I research and based in Central London
-
Over 1,000 trials completed for global biopharma and biotech sponsors
-